Zydus Lifesciences gets exclusive marketing rights for CanAssist Breast
The prognostic test for breast cancer brings in 95% precision in gauging whether patients need chemotherapy or not
The prognostic test for breast cancer brings in 95% precision in gauging whether patients need chemotherapy or not